- Feb 9, 2007
- 1,841
- 25
http://www.psi.org/our_programs/products/deworming.html
De-Worming
Parasitic infections contribute to a range of health problems including malnutrition, anemia, and slow cognitive development. Around 2 billion people worldwide harbor schistosomiasis and soil-transmitted helminth (STH) infections. 300 million people, 50% of them school-aged children, are severely ill due to worms. Intestinal worms account for an estimated 11-12% of the total disease burden for school-aged children (5 to 14 years) in low-income countries. Regular de-worming allows people to avoid the worst effects of chronic worm infections, even without an improvement in sanitation.
There are 2 types of de-worming tablets, albendazole and mebendazole. Regular use of inexpensive albendazole or mebendazole tablets has been shown to improve the health of individuals suffering from worm infestations, with reduction of transmission in school-aged children having positive externalities for reduction of the disease burden in the entire population.
Efficacy of albendazole was demonstrated by a World Health Organization (WHO) assessment of de-worming among pre-school children in Nepal. Results showed a 43% reduction in worm-infection rate, 76% reduction in anemia prevalence, and improvement in the mean hemoglobin level from 11g/dl to 12.2g/dl after only two rounds of de-worming. Treatment is safe, even when given to uninfected children. A WHO taskforce recommended that pregnant women should be treated. The treatment of infants under 12 months should be decided on a case-by-case basis.
One 400mg tablet of albendazole or 500mg tablet of mebendazole should be taken one to three times a year depending upon the worm burden in the area. Due to the likelihood of re-infection, it is important to treat the whole family, with a focus on children aged 2-12 and pregnant women. Children aged 12 - 24 months can be given either the full dose of mebendazole or a half dose, 200mg, of albendazole.
PSI will launch a pilot program social marketing a family pack of de-worming tablets in Ethiopia in the fall of 2005.
more
http://www.google.com/search?hl=en&q=de+worming+&btnG=Search
De-Worming
Parasitic infections contribute to a range of health problems including malnutrition, anemia, and slow cognitive development. Around 2 billion people worldwide harbor schistosomiasis and soil-transmitted helminth (STH) infections. 300 million people, 50% of them school-aged children, are severely ill due to worms. Intestinal worms account for an estimated 11-12% of the total disease burden for school-aged children (5 to 14 years) in low-income countries. Regular de-worming allows people to avoid the worst effects of chronic worm infections, even without an improvement in sanitation.
There are 2 types of de-worming tablets, albendazole and mebendazole. Regular use of inexpensive albendazole or mebendazole tablets has been shown to improve the health of individuals suffering from worm infestations, with reduction of transmission in school-aged children having positive externalities for reduction of the disease burden in the entire population.
Efficacy of albendazole was demonstrated by a World Health Organization (WHO) assessment of de-worming among pre-school children in Nepal. Results showed a 43% reduction in worm-infection rate, 76% reduction in anemia prevalence, and improvement in the mean hemoglobin level from 11g/dl to 12.2g/dl after only two rounds of de-worming. Treatment is safe, even when given to uninfected children. A WHO taskforce recommended that pregnant women should be treated. The treatment of infants under 12 months should be decided on a case-by-case basis.
One 400mg tablet of albendazole or 500mg tablet of mebendazole should be taken one to three times a year depending upon the worm burden in the area. Due to the likelihood of re-infection, it is important to treat the whole family, with a focus on children aged 2-12 and pregnant women. Children aged 12 - 24 months can be given either the full dose of mebendazole or a half dose, 200mg, of albendazole.
PSI will launch a pilot program social marketing a family pack of de-worming tablets in Ethiopia in the fall of 2005.
more
http://www.google.com/search?hl=en&q=de+worming+&btnG=Search